{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T22:02:34Z","timestamp":1792015354394,"version":"4.4.0"},"reference-count":143,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2024,11,17]],"date-time":"2024-11-17T00:00:00Z","timestamp":1731801600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Vaccines"],"published-print":{"date-parts":[[2024,12,31]]},"DOI":"10.1080\/14760584.2024.2428243","type":"journal-article","created":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T10:17:12Z","timestamp":1731579432000},"page":"1052-1067","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":5,"title":["Adult risk groups for vaccine preventable respiratory infections: an overview of the UK environment"],"prefix":"10.1080","volume":"23","author":[{"given":"Charles","family":"Reynard","sequence":"first","affiliation":[{"name":"Pfizer Ltd","place":["Walton Oaks, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Campling","sequence":"additional","affiliation":[{"name":"Pfizer Ltd","place":["Walton Oaks, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam L","family":"Gordon","sequence":"additional","affiliation":[{"name":"Queen Mary University of London","place":["London, UK"]},{"name":"Barts Health NHS Trust and Whipps Cross Hospital","place":["London, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Kassianos","sequence":"additional","affiliation":[{"name":"Royal College of General Practitioners","place":["London, UK"]},{"name":"British Global & Travel Health Association","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Hsuan","family":"Liu","sequence":"additional","affiliation":[{"name":"OPEN Health","place":["London, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Richter","sequence":"additional","affiliation":[{"name":"University of Birmingham","place":["Birmingham, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Vyse","sequence":"additional","affiliation":[{"name":"Pfizer Ltd","place":["Walton Oaks, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dexter J","family":"Wiseman","sequence":"additional","affiliation":[{"name":"Imperial College London","place":["London, UK"]},{"name":"Chelsea and Westminster NHS Foundation Trust","place":["London, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Wright","sequence":"additional","affiliation":[{"name":"Pfizer Ltd","place":["Walton Oaks, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gillian","family":"Ellsbury","sequence":"additional","affiliation":[{"name":"Pfizer Ltd","place":["Walton Oaks, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2024,11,17]]},"reference":[{"key":"e_1_3_6_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(18)30310-4"},{"key":"e_1_3_6_4_1","unstructured":"Respiratory Medicine AM. GIRFT Programme National Specialty Report. 2021 [cited 2023 Nov 23]. Available from: https:\/\/www.gettingitrightfirsttime.co.uk\/wp-content\/uploads\/2022\/07\/Respiratory-Medicine-Oct21L.pdf"},{"key":"e_1_3_6_5_1","unstructured":"NHS England. NHS long term plan. 2019 [cited 2023 Apr 4]. Available from: https:\/\/www.longtermplan.nhs.uk\/"},{"key":"e_1_3_6_6_1","unstructured":"Lung Foundation B. Out in the cold \u2013 lung disease the hidden driver of NHS winter pressure. 2017 [cited 2023 Sep 26]. Available from: https:\/\/www.blf.org.uk\/policy\/out-in-the-cold"},{"key":"e_1_3_6_7_1","unstructured":"UK Health Security Agency. Influenza: the green book chapter 19. 2022 [cited 2023 Sep 22]. Available from: https:\/\/www.gov.uk\/government\/publications\/influenza-the-green-book-chapter-19"},{"key":"e_1_3_6_8_1","unstructured":"UK Health Security Agency. Pneumococcal: the green book chapter 25. 2023 [cited 2023 Oct 2]. Available from: https:\/\/www.gov.uk\/government\/publications\/pneumococcal-the-green-book-chapter-25"},{"key":"e_1_3_6_9_1","unstructured":"UK Health Security Agency. COVID-19: the green book chapter 14a. 2024 [cited 2024 Feb 20]. Available from: https:\/\/www.gov.uk\/government\/publications\/covid-19-the-green-book-chapter-14a"},{"key":"e_1_3_6_10_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines11050945"},{"key":"e_1_3_6_11_1","unstructured":"Joint Committee on Vaccination and Immunisation. Joint Committee on Vaccination and Immunisation. Minute of the meeting held on. Jun 2023. 2023 [cited 2023 Oct 30]. Available from 07. https:\/\/app.box.com\/s\/iddfb4ppwkmtjusir2tc\/file\/1262409204637"},{"key":"e_1_3_6_12_1","unstructured":"UK Health Security Agency. Introduction of new NHS vaccination programmes against respiratory syncytial virus (RSV). 2024 [cited 2024 Jul 1]. Available from: https:\/\/www.gov.uk\/government\/publications\/respiratory-syncytial-virus-rsv-vaccination-programmes-letter\/introduction-of-new-nhs-vaccination-programmes-against-respiratory-syncytial-virus-rsv#programme-for-older-adults-aged-75-to-79-years-old"},{"key":"e_1_3_6_13_1","unstructured":"UK Health Security Agency. Respiratory syncytial virus: the green book chapter 27a. 2015 [cited 2023 Sep 22]. Available from: https:\/\/www.gov.uk\/government\/publications\/respiratory-syncytial-virus-the-green-book-chapter-27a"},{"key":"e_1_3_6_14_1","volume-title":"ISPPD","author":"Wright H","unstructured":"P237 are adults at increased risk of pneumococcal infectionoptimally served by current UK vaccination recommendations? In: Wright H, Campling J, Czudek C, et al. editors. ISPPD. South Africa: Cape Town; [2024 Mar 17\u201320]."},{"key":"e_1_3_6_15_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00358"},{"key":"e_1_3_6_16_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202112-2700OC"},{"key":"e_1_3_6_17_1","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2023.2256394"},{"key":"e_1_3_6_18_1","unstructured":"UK Health Security Agency. Autumn\/Winter (AW) 2023-24 flu and COVID-19 seasonal campaign. 2023 [cited 2023 Oct 2]. Available from: https:\/\/www.england.nhs.uk\/long-read\/autumn-winter-aw-2023-24-flu-and-covid-19-seasonal-campaign\/"},{"key":"e_1_3_6_19_1","unstructured":"Joint Committee on Vaccination and Immunisation. Joint Committee on Vaccination and Immunisation. Advice on influenza vaccines for 2023\/24. 2023 [cited 2023 Nov 16]. Available from: https:\/\/app.box.com\/s\/t5ockz9bb6xw6t2mrrzb144njplimfo0\/file\/1079253178131"},{"key":"e_1_3_6_20_1","unstructured":"Public Health Scotland. Winter flu and COVID-19 vaccination programme. 2023 [cited 2023 Dec 4]. Available from: https:\/\/publichealthscotland.scot\/news\/2023\/august\/winter-flu-and-covid-19-vaccination-programme\/"},{"key":"e_1_3_6_21_1","unstructured":"NI Direct. Flu vaccine. 2024 [cited 2024 Feb 20]. Available from: https:\/\/www.nidirect.gov.uk\/articles\/flu-vaccine"},{"key":"e_1_3_6_22_1","unstructured":"House of Commons Science and Technology Committee. Flu vaccination programme in England. Ninth Report of Session 2017\u201319. 2018 [cited 2023 Nov 16]. Available from: https:\/\/publications.parliament.uk\/pa\/cm201719\/cmselect\/cmsctech\/853\/853.pdf"},{"key":"e_1_3_6_23_1","unstructured":"UK Health Security Agency. Surveillance of influenza and other seasonal respiratory viruses in winter 2021 to 2022. Updated 3 July 2023. 2023 [cited 2023 Sep 22]. https:\/\/www.gov.uk\/government\/statistics\/annual-flu-reports\/surveillance-of-influenza-and-other-seasonal-respiratory-viruses-in-winter-2021-to-2022"},{"key":"e_1_3_6_24_1","article-title":"Surveillance of influenza and other seasonal respiratory viruses in the UK, winter 2022 to 2023","author":"UK Health Security Agency","year":"2023","unstructured":"UK Health Security Agency. Surveillance of influenza and other seasonal respiratory viruses in the UK, winter 2022 to 2023. Updated. 2023 [Updated 2023 July 3; cited 2023 September 22]. Available from 3. https:\/\/www.gov.uk\/government\/statistics\/annual-flu-reports\/surveillance-of-influenza-and-other-seasonal-respiratory-viruses-in-the-uk-winter-2022-to-2023","journal-title":"Updated"},{"key":"e_1_3_6_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2019.10.071"},{"key":"e_1_3_6_26_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp2314801"},{"key":"e_1_3_6_27_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiab269"},{"key":"e_1_3_6_28_1","unstructured":"Department of Health & Social Care. JCVI statement on the COVID-19 vaccination programme for autumn 2023. May 2023. 2023 [cited 2024 Aug 14]. Available from 26. https:\/\/www.gov.uk\/government\/publications\/covid-19-autumn-2023-vaccination-programme-jcvi-advice-26-may-2023\/jcvi-statement-on-the-covid-19-vaccination-programme-for-autumn-2023-26-may-2023"},{"key":"e_1_3_6_29_1","unstructured":"Department of Health and Social Care. Government accepts advice on 2024 autumn COVID-19 vaccine programme. 2024 [cited 2024 Aug 14]. Available from: https:\/\/www.gov.uk\/government\/news\/government-accepts-advice-on-2024-autumn-covid-vaccine-programme?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=c4d64e58-c942-4b07-be0a-c163552abeb6&utm_content=weekly"},{"key":"e_1_3_6_30_1","unstructured":"Department of Health & Social Care. JCVI statement on the COVID-19 vaccination programme for autumn 2024 Apr 2024. 2024 [cited 2024 Aug 14]. Available from 8. https:\/\/www.gov.uk\/government\/publications\/covid-19-autumn-2024-vaccination-programme-jcvi-advice-8-april-2024\/jcvi-statement-on-the-covid-19-vaccination-programme-for-autumn-2024-8-april-2024"},{"key":"e_1_3_6_31_1","unstructured":"UK Health Security Agency. COVID-19 vaccine surveillance report: 23 September 2021 (week 38). 2021 [cited 2023 Oct 3]. Available from: https:\/\/www.gov.uk\/government\/publications\/covid-19-vaccine-surveillance-report"},{"key":"e_1_3_6_32_1","unstructured":"UK Health Security Agency. COVID-19 vaccine surveillance report: 24 March 2022 (week 12). 2023 [cited 2023 Oct 30]. Available from: https:\/\/www.gov.uk\/government\/publications\/covid-19-vaccine-weekly-surveillance-reports"},{"key":"e_1_3_6_33_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2213836"},{"key":"e_1_3_6_34_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-015-1218-z"},{"key":"e_1_3_6_35_1","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0105-2022"},{"key":"e_1_3_6_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2022.100473"},{"key":"e_1_3_6_37_1","doi-asserted-by":"publisher","DOI":"10.1203\/00006450-200209000-00009"},{"key":"e_1_3_6_38_1","article-title":"RSVpreF adult clinical development update","author":"Vaccine Research and Development, Pfizer, Pearl River, NY","year":"2024","unstructured":"Vaccine Research and Development, Pfizer, Pearl River, NY. RSVpreF adult clinical development update. Munjal I, editor. ACIP Meet. Virtual; 2024 Jun 26. https:\/\/www.cdc.gov\/acip\/downloads\/slides-2024-06-26-28\/02-RSV-Adult-Munjal-508.pdf","journal-title":"ACIP Meet"},{"key":"e_1_3_6_39_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciae010"},{"key":"e_1_3_6_40_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7229a4"},{"key":"e_1_3_6_41_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-021-00542-7"},{"key":"e_1_3_6_42_1","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens12091118"},{"key":"e_1_3_6_43_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-018-0001-8"},{"key":"e_1_3_6_44_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-36624-8"},{"key":"e_1_3_6_45_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2023.2257048"},{"key":"e_1_3_6_46_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12979-019-0164-9"},{"key":"e_1_3_6_47_1","unstructured":"Public Health Scotland. Scottish Vaccine Update. 2024 [cited 2024 Oct 17]. Available from: https:\/\/publichealthscotland.scot\/publications\/scottish-vaccine-update\/scottish-vaccine-update-issue-83\/about-the-winter-202425-programme\/"},{"key":"e_1_3_6_48_1","unstructured":"Department of Health & Social Care. JCVI statement on the COVID-19 booster vaccination programme for autumn 2022. 2022 [cited 2024 Oct 17]. Available from: https:\/\/www.gov.uk\/government\/publications\/covid-19-vaccines-for-autumn-2022-jcvi-advice-15-august-2022\/jcvi-statement-on-the-covid-19-booster-vaccination-programme-for-autumn-2022-update-15-august-2022#:~:text=The%20primary%20aim%20of%20the booster%20vaccine%20in%20autumn%202022"},{"key":"e_1_3_6_49_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m1985"},{"key":"e_1_3_6_50_1","doi-asserted-by":"publisher","DOI":"10.1007\/s15010-022-01787-x"},{"key":"e_1_3_6_51_1","unstructured":"Electronic Medicines Compendium. Abrysvo powder and solvent for solution for injection. 2023 [cited 2024 Mar 27]. Available from: https:\/\/www.medicines.org.uk\/emc\/product\/15309\/smpc#gref"},{"key":"e_1_3_6_52_1","unstructured":"Electronic Medicines Compendium. Arexvy powder and suspension for suspension for injection. Respiratory syncytial virus (RSV) vaccine (recombinant adjuvanted). 2023 [cited 2023 Dec 4]. Available from: https:\/\/www.medicines.org.uk\/emc\/files\/pil.14951.pdf"},{"key":"e_1_3_6_53_1","unstructured":"U.S. Food & Drug Administration. AREXVY. 2024 [cited 2024 Aug 27]. Available from: https:\/\/www.fda.gov\/vaccines-blood-biologics\/arexvy"},{"key":"e_1_3_6_54_1","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10081938"},{"key":"e_1_3_6_55_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-021-02734-w"},{"key":"e_1_3_6_56_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2023-078135"},{"key":"e_1_3_6_57_1","doi-asserted-by":"publisher","DOI":"10.1002\/oby.23178"},{"key":"e_1_3_6_58_1","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0098-2022"},{"key":"e_1_3_6_59_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2021-052777"},{"key":"e_1_3_6_60_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-021-06536-3"},{"key":"e_1_3_6_61_1","unstructured":"Australian Government. Department of Health and Aged Care. Australian Immunisation Handbook. Vaccine preventable diseases. 2024 [cited 2024 Apr 4]. Available from: https:\/\/immunisationhandbook.health.gov.au\/contents\/vaccine-preventable-diseases"},{"key":"e_1_3_6_62_1","unstructured":"Medicines and Healthcare products Regulatory Agency. All cochlear implants - update on immunisation recommendations. 2014 [cited 2023 Nov 22]. Available from: https:\/\/www.gov.uk\/drug-device-alerts\/medical-device-alert-all-cochlear-implants-update-on-immunisation-recommendations"},{"key":"e_1_3_6_63_1","doi-asserted-by":"publisher","DOI":"10.1093\/pubmed\/fdh188"},{"key":"e_1_3_6_64_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(18)30245-7"},{"key":"e_1_3_6_65_1","unstructured":"Industrial Injuries Advisory Council (IIAC). COVID-19 and occupational impacts. 2022 [cited 2024 Mar 19]. Available from: https:\/\/www.gov.uk\/government\/publications\/covid-19-and-occupational-impacts"},{"key":"e_1_3_6_66_1","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/afac097"},{"key":"e_1_3_6_67_1","unstructured":"National Institute for Health and Care Excellence. COVID-19 rapid guideline: managing COVID-19. 2023 [cited 2023 Oct 12]. Available from: https:\/\/www.nice.org.uk\/guidance\/ng191"},{"key":"e_1_3_6_68_1","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.050051"},{"key":"e_1_3_6_69_1","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/afab026"},{"key":"e_1_3_6_70_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(21)00460-6"},{"key":"e_1_3_6_71_1","doi-asserted-by":"publisher","DOI":"10.1111\/imj.15698"},{"key":"e_1_3_6_72_1","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyac137"},{"key":"e_1_3_6_73_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-024-09210-6"},{"key":"e_1_3_6_74_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0294895"},{"key":"e_1_3_6_75_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-021-06600-y"},{"key":"e_1_3_6_76_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2589-7500(22)00187-X"},{"key":"e_1_3_6_77_1","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/afx201"},{"key":"e_1_3_6_78_1","doi-asserted-by":"publisher","DOI":"10.1111\/imm.13450"},{"key":"e_1_3_6_79_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1010907"},{"key":"e_1_3_6_80_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2013.11.013"},{"key":"e_1_3_6_81_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2019.12.056"},{"key":"e_1_3_6_82_1","unstructured":"Centers for Disease Control and Prevention. Manual for the surveillance of vaccine-preventable diseases. Chapter 6: influenza. 2023 [cited 2023 Sep 22]. Available from: https:\/\/www.cdc.gov\/vaccines\/pubs\/surv-manual\/chpt06-influenza.html"},{"key":"e_1_3_6_83_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-023275"},{"key":"e_1_3_6_84_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2521-4"},{"key":"e_1_3_6_85_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(20)30272-2"},{"key":"e_1_3_6_86_1","doi-asserted-by":"publisher","DOI":"10.1136\/jech-2020-215810"},{"key":"e_1_3_6_87_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-2667(23)00079-8"},{"key":"e_1_3_6_88_1","unstructured":"UK Health Security Agency. Seasonal influenza vaccine uptake in GP patients. Winter season 2022 to 2023. 2023 [cited 2023 Oct 4]. Available from: https:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/1177042\/GP-patients-flu-annual-report-2022-2023.pdf"},{"key":"e_1_3_6_89_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciad522"},{"key":"e_1_3_6_90_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjresp-2020-000644"},{"key":"e_1_3_6_91_1","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyac158"},{"key":"e_1_3_6_92_1","doi-asserted-by":"publisher","DOI":"10.18332\/tid\/123845"},{"key":"e_1_3_6_93_1","unstructured":"Centers for Disease Control and Prevention. People with certain medical conditions. 2023 [cited 2024 Apr 4]. Available from: https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/need-extra-precautions\/people-with-medical-conditions.html"},{"issue":"1","key":"e_1_3_6_94_1","first-page":"2","article-title":"The burden of respiratory syncytial virus: understanding impacts on the NHS, society and economy","volume":"10","author":"Fusco F","year":"2022","unstructured":"Fusco F, Hocking L, Stockwell S, et al. The burden of respiratory syncytial virus: understanding impacts on the NHS, society and economy. Rand Health Q. 2022;10(1):2.","journal-title":"Rand Health Q"},{"key":"e_1_3_6_95_1","doi-asserted-by":"publisher","DOI":"10.1111\/irv.13188"},{"key":"e_1_3_6_96_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1750-2659.2012.00345.x"},{"key":"e_1_3_6_97_1","doi-asserted-by":"publisher","DOI":"10.1111\/irv.12910"},{"issue":"229","key":"e_1_3_6_98_1","first-page":"S70","article-title":"Respiratory syncytial virus-associated hospitalisation in adults with comorbidities in two European countries: a modelling study","volume":"1","author":"Osei-Yeboah R","year":"2023","unstructured":"Osei-Yeboah R, Johannesen CK, Egeskov-Cavling AM, et al. Respiratory syncytial virus-associated hospitalisation in adults with comorbidities in two European countries: a modelling study. J Infect Dis. 2023;1(229):S70\u2013S77.","journal-title":"J Infect Dis"},{"key":"e_1_3_6_99_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiac150"},{"key":"e_1_3_6_100_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202308-1320OC"},{"key":"e_1_3_6_101_1","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofac300"},{"key":"e_1_3_6_102_1","unstructured":"Britton A. RSV vaccination in older adults: Work Group interpretations. 2024 [cited 2024 Mar 11]. Available from: https:\/\/stacks.cdc.gov\/view\/cdc\/148678"},{"key":"e_1_3_6_103_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2022-072976"},{"key":"e_1_3_6_104_1","doi-asserted-by":"publisher","DOI":"10.1057\/s41292-021-00266-0"},{"key":"e_1_3_6_105_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40520-023-02380-4"},{"key":"e_1_3_6_106_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2014.10.047"},{"key":"e_1_3_6_107_1","doi-asserted-by":"publisher","DOI":"10.1038\/ni.2588"},{"key":"e_1_3_6_108_1","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofad513"},{"key":"e_1_3_6_109_1","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.36342"},{"key":"e_1_3_6_110_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiad428"},{"key":"e_1_3_6_111_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2024.01.009"},{"key":"e_1_3_6_112_1","doi-asserted-by":"publisher","DOI":"10.3399\/bjgp17X692645"},{"key":"e_1_3_6_113_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines11020382"},{"key":"e_1_3_6_114_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2021.04.002"},{"key":"e_1_3_6_115_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2022-070615"},{"key":"e_1_3_6_116_1","unstructured":"Department of Health & Social Care. NHS public health functions agreement 2019-20. Public health functions to be exercised by NHS England. 2019 [cited 2023 Nov 10]. Available from: https:\/\/assets.publishing.service.gov.uk\/media\/5df8a959e5274a08f6966b46\/NHS_public_health_functions_agreement_2019-20.pdf"},{"key":"e_1_3_6_117_1","article-title":"Pneumococcal Polysaccharide Vaccine (PPV) coverage report, England, April 2021 to March 2022","author":"UK Health Security Agency","year":"2023","unstructured":"UK Health Security Agency. Pneumococcal Polysaccharide Vaccine (PPV) coverage report, England, April 2021 to March 2022. Updated. 2023 Jul 2023. cited Sep 22]. Available from 17. https:\/\/www.gov.uk\/government\/publications\/pneumococcal-polysaccharide-vaccine-ppv-vaccine-coverage-estimates\/pneumococcal-polysaccharide-vaccine-ppv-coverage-report-england-april-2021-to-march-2022","journal-title":"Updated"},{"key":"e_1_3_6_118_1","unstructured":"UK Health Security Agency. Seasonal influenza vaccine uptake in GP patients in England: winter season 2023 to 2024. 2024 [cited 2024 Oct 17]. https:\/\/www.gov.uk\/government\/statistics\/seasonal-influenza-vaccine-uptake-in-gp-patients-winter-season-2023-to-2024\/seasonal-influenza-vaccine-uptake-in-gp-patients-in-england-winter-season-2023-to-2024"},{"key":"e_1_3_6_119_1","unstructured":"UK Health Security Agency. National Influenza and COVID-19 surveillance report. Week 3 report (up to week 2 2024 data). 2024 [cited 2024 Oct 17]. Available from: https:\/\/assets.publishing.service.gov.uk\/media\/65a91a7ab2f3c60013e5d52b\/Weekly-flu-and-COVID-19-surveillance-report-week-3.pdf"},{"key":"e_1_3_6_120_1","unstructured":"UK Health Security Agency. Pneumococcal polysaccharide vaccine (PPV) coverage report England April 2021 to March 2022. Updated. Jul 2023. 2023 [cited 2023 Oct 4]. Available from 17. Available from: https:\/\/www.gov.uk\/government\/publications\/pneumococcal-polysaccharide-vaccine-ppv-vaccine-coverage-estimates\/pneumococcal-polysaccharide-vaccine-ppv-coverage-report-england-april-2021-to-march-2022#methods"},{"key":"e_1_3_6_121_1","unstructured":"NHS England. Autumn Winter COVID vaccinations for SIS and IS 29 February 2024. 2024 [2023-24 [cited Oct 17]. Available from: https:\/\/www.england.nhs.uk\/statistics\/statistical-work-areas\/covid-19-vaccinations\/"},{"key":"e_1_3_6_122_1","unstructured":"Royal Society for Public Health. Moving the needle: promoting vaccination uptake across the life course. 2019 [cited 2023 Oct 16]. Available from: https:\/\/www.rsph.org.uk\/our-work\/policy\/vaccinations\/moving-the-needle-promoting-vaccination-uptake-across-the-life-course.html#:~:text=the%20life%20course- Moving%20the%20Needle%3A%20Promoting%20vaccination%20uptake%20across%20the%20life%20course stages%20of%20the%20life%20course"},{"key":"e_1_3_6_123_1","unstructured":"ClinicalTrial.gov. A safety reactogenicity and immunogenicity study of mRNA-1045 (influenza and respiratory syncytial virus [RSV]) or mRNA-1230 (influenza RSV and severe acute respiratory syndrome coronavirus 2 [SARS-CoV-2]) vaccine in adults 50 to 75 years old. 2022 [cited Mar 19]. Available from: https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT05585632"},{"key":"e_1_3_6_124_1","unstructured":"ClinicalTrial.gov. A study to evaluate the safety tolerability and immunogenicity of combined modified RNA vaccine candidates against COVID-19 and influenza. 2022 [cited Mar 19]. Available from: https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT05596734"},{"key":"e_1_3_6_125_1","unstructured":"ClinicalTrial.gov. A study to evaluate the safety and immunogenicity of COVID-19 and influenza combination vaccine (COVID-19). 2022 [updated January 26 2023; cited Mar 19]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT05519839 2024."},{"key":"e_1_3_6_126_1","unstructured":"ClinicalTrial.gov. A study of mRNA-1083 (SARS-CoV-2 and influenza) vaccine in healthy adult participants \u226550 years of age. 2023 [updated December 20 2023; cited Mar 19]. Available from: https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT06097273 2024."},{"key":"e_1_3_6_127_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002829"},{"key":"e_1_3_6_128_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1812388116"},{"key":"e_1_3_6_129_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-021-06785-2"},{"key":"e_1_3_6_130_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2013.02.007"},{"key":"e_1_3_6_131_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.18966"},{"key":"e_1_3_6_132_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2023.104493"},{"key":"e_1_3_6_133_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI157124"},{"key":"e_1_3_6_134_1","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.2365"},{"key":"e_1_3_6_135_1","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyab081"},{"key":"e_1_3_6_136_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa1728"},{"key":"e_1_3_6_137_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiab128"},{"key":"e_1_3_6_138_1","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0076-2015"},{"key":"e_1_3_6_139_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)00383-X"},{"key":"e_1_3_6_140_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(17)30120-0"},{"key":"e_1_3_6_141_1","unstructured":"Public Health England. Point of care tests for influenza and other respiratory viruses. Winter 2019 to 2020. 2019 [cited 2023 Dec 8]. Available from: https:\/\/www.gov.uk\/government\/publications\/point-of-care-tests-for-influenza-and-other-respiratory-viruses"},{"key":"e_1_3_6_142_1","doi-asserted-by":"publisher","DOI":"10.1021\/acsptsci.0c00027"},{"key":"e_1_3_6_143_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40121-023-00758-5"},{"key":"e_1_3_6_144_1","unstructured":"Royal College of General Practitioners Research and Surveillance Centre. RCGP Research and Surveillance Centre. 2023 [cited 2023 Dec 12]. Available from: https:\/\/www.rcgp.org.uk\/representing-you\/research-at-rcgp\/research-surveillance-centre"},{"key":"e_1_3_6_145_1","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01569-2022"}],"container-title":["Expert Review of Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14760584.2024.2428243","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T09:47:40Z","timestamp":1759830460000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14760584.2024.2428243"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,17]]},"references-count":143,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,12,31]]}},"alternative-id":["10.1080\/14760584.2024.2428243"],"URL":"https:\/\/doi.org\/10.1080\/14760584.2024.2428243","relation":{},"ISSN":["1476-0584","1744-8395"],"issn-type":[{"value":"1476-0584","type":"print"},{"value":"1744-8395","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,17]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierv20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierv20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2024-10-02","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-11-06","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-11-17","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}